Table 3: Few marketed preparations for treatment of keratoconjunctivitis sicca.

ManufacturerBrandContentDelivery system and indication

Allergan, Inc.Restasis (by prescription)Cyclosporin A 0.05% w/v Oil-based emulsion
DED treatment
Refresh Optive Contains 2 osmolytes L-carnitine and erythritol and CMC sodium 5 mgEye drops

Sun Pharma Ind. Ltd.CyclomuneCyclosporin A 0.05% w/vDrops
DED treatment

Bausch & Lomb Inc.LotemaxLoteprednol etabonate 0.5% Suspension drops (steroid) for short-term therapy

Novartis Ltd.Voltaren Diclofenac sodium ophthalmic solution) 0.1%Drops

FDC Ltd.ZO-D eye dropsOfloxacin and dexamethasoneDrops

Allergan India Pvt. Ltd.Acular LSKetorolac tromethamine 0.4%Drops
Toba DM
Toba F
Tobramycin USP
Tobramycin and dexamethasone
Tobramycin and fluorometholone

Ocusoft, Inc.Retaine
Cationic O/W emulsion technology Hypotonic emulsion provides lubrication

Otsuka Pharmaceuticals Mucosta ophthalmic suspension UD2%Rebamipide Marketed in China, Japan, Indonesia, Malaysia, and Thailand

Advanced Vision ResearchThera tears nutritionOmega 3 fatty acidsGel capsules